首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Anti-malarial activity of new N-acetyl-l-leucyl-l-leucyl-l-norleucinal (ALLN) derivatives against Plasmodium falciparum
【24h】

Anti-malarial activity of new N-acetyl-l-leucyl-l-leucyl-l-norleucinal (ALLN) derivatives against Plasmodium falciparum

机译:新的N-乙酰基-1-亮氨酰-1-亮氨酰-1-净核苷(ALLN)衍生物对恶性疟原虫的抗疟活性

获取原文
获取原文并翻译 | 示例
       

摘要

Malaria is the most common of the parasitic diseases in tropical and subtropical regions. Adverse side effects of anti-malarial drugs have precluded them as a potential clinical drug. In this study, novel derivatives of N-acetyl-l-leucyl-l-leucyl-l-norleucinal (ALLN) based on a variety of dipeptidyl ??,??-unsaturated amides containing lysine as a part were synthesized and evaluated. Lower toxicity was achieved by reducing or eliminating the tendency of forming chemically reactive and toxic intermediates and metabolites. The synthesized compounds were evaluated for anti-malarial efficacy against Plasmodium falciparum and cytotoxicity in human epitheloid carcinoma cervix (HeLa cells) by estimating the therapeutic index (TI). N-Methyl amide with N??-Boc protection among them exhibited strong anti-malarial activity and N-methyl amide with N??-m-methylbenzyl amide showed excellent anti-malarial activity with much lower toxicity than the ALLN. Therefore, the two chemicals, as well as the underlying design rationale, could be useful in the discovery and development of new anti-malarial drugs. ? 2012 Elsevier Ltd. All rights reserved.
机译:疟疾是热带和亚热带地区最常见的寄生虫病。抗疟疾药物的不良副作用使它们无法成为潜在的临床药物。在这项研究中,合成和评估了基于各种赖氨酸为一部分的二肽基γ,β-不饱和酰胺的N-乙酰基-1-亮氨酰-1-亮氨酰-1-正亮氨酸衍生物(ALLN)。通过减少或消除形成化学反应性和有毒中间体和代谢物的趋势,可以降低毒性。通过估计治疗指数(TI),评估了合成的化合物对恶性疟原虫的抗疟药功效以及对人上皮性宫颈癌(HeLa细胞)的细胞毒性。其中具有N + -Boc保护的N-甲基酰胺具有很强的抗疟活性,具有N +-间-甲基苄基酰胺的N-甲基酰胺具有极好的抗疟活性,且毒性比ALLN低得多。因此,这两种化学物质以及其基本的设计原理在发现和开发新的抗疟药方面可能会很有用。 ? 2012 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号